Age: 28
Free Agency: 2024 (UFA)
Accrued Seasons: 3
- Height: 6'3"
- Weight: 237
- College: Wisconsin
- Entry: 2019 Draft, Round 5, #143 overall (Giants)
- 2023 Salary Cap Charge: $940,000 (0.42% of cap)
- 2023 Cash Payout: $1,080,000 (0.41% of spending)
- 2023 Cash to Cap Ratio: 1.15
- Contract Value: $1,080,000 ($1,080,000 APY)
- Fully Guaranteed Money: $0
- Contract Ranking: 118/256 at LB
Current Contract
(SFA, signed 2023)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Cap Number | Cap % | Dead Money & Cap Savings | |||
|---|---|---|---|---|---|---|---|---|
| 2023 | 28 | $1,080,000 | $940,000 | 0.4% | ||||
| Total | $1,080,000 | $940,000 | ||||||
Cash Flows
- fully earned money
- unearned or partially earned money
$1.1M
| 2023 | |
|---|---|
| Cash Due | $1,080,000 |
| Running Cash | $1,080,000 |
Career Earnings: $2,800,172
Career APY: $700,043
Potential Earnings: $3,612,116
Total Guarantees: $672,352
Largest Cash Payment: $1,080,000 (2023)
Largest Cap Number: $940,000 (2023)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Giants | Drafted | Claimed | 2019 | 4 | $2,856,176 | $714,044 | $336,176 | $741,705 | 26.0% | $741,705 |
| Vikings | Drafted | Terminated | 2019 | 4 | $2,856,176 | $714,044 | $336,176 | $1,525,000 | 53.4% | $762,500 |
| Vikings | Practice | Expired | 2022 | 1 | $317,700 | $317,700 | $0 | $265,411 | 83.5% | $265,411 |
| Vikings | Practice | Elevated | 2022 | 1 | $317,700 | $317,700 | $0 | $0 | 0.0% | $0 |
| Saints | SFA | Active | 2023 | 1 | $1,080,000 | $1,080,000 | $0 | $0 | 0.0% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Giants | 1 | $741,705 | $741,705 | $489,573 | 0.0% | $252,132 | 0.0% |
| Vikings | 3 | $2,058,467 | $686,156 | $1,790,411 | 0.0% | $268,056 | 0.0% |
| Saints | 0 | $0 | $0 | $0 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Cap Number | Cap % | Cash Paid | |
|---|---|---|---|---|---|---|---|
| 2019 | Giants | $495,000 | $84,044 | $489,573 | 0.3% | $741,705 | |
| 2020 | Vikings | $675,000 | $0 | $675,000 | 0.3% | $675,000 | |
| 2021 | Vikings | $850,000 | $0 | $850,000 | 0.5% | $850,000 | |
| 2022 | Vikings | $317,700 | $0 | $265,411 | 0.1% | $265,411 | |
| 2023 | Saints | $1,080,000 | $0 | $940,000 | 0.4% | $1,080,000 | |
| Total | $3,417,700 | $84,044 | $3,219,984 | $3,612,116 | |||
Statistics
| Year | Games Played | Games Inactive | Snaps | Tackles | Negative Plays | Interceptions | Fumbles | TD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Defense | Special | Solo | Assist | Sacks | Yards | TFL | QB Hits | Pass Def. | INT | Yards | Forced | Rec. | Yards | |||
| 2019 | 4 | 12 | 0 | 17.2% | 6.5% | 10 | 10 | 1 | 2 | 2 | 1 | 2 | 2 | 18 | 0 | 0 | 0 | 0 |
| 2020 | 14 | 0 | 1 | 0.1% | 44.1% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 12 | 0 | 0 | 0.0% | 44.2% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 1.4% | 2.6% | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $602,000 | $1,080,000 |
| Injury Adjusted | $602,000 | $1,080,000 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.